GLP-1 Drugs and Alcohol: Can You Drink, and Do They Curb Drinking?

The FDA labels for Wegovy, Ozempic and Zepbound do not ban alcohol, but both alcohol and these drugs can upset the stomach and cause dehydration, and alcohol can add to the low-blood-sugar risk for people who also take insulin or a sulfonylurea. The bigger news is in the trials: in a 2026 Lancet trial of 108 people with alcohol use disorder and obesity, weekly semaglutide 2.4 mg cut heavy drinking days by 41 percentage points versus 26 on placebo over 26 weeks. That is promising, but no GLP-1 is FDA-approved to treat drinking.

By Kymata Labs Editorial · Published Oct 11, 2026 · Updated Oct 11, 2026 · How we rank

Facts checked Oct 11, 2026 · Medical review pending

Quick answer

Can you drink on a GLP-1? The labels have no alcohol warning or ban. Drinking can add to nausea, vomiting and dehydration (which the labels link to kidney injury), and with insulin or a sulfonylurea it raises the risk of low blood sugar. Ask your prescriber what is reasonable for you.
Do GLP-1s reduce drinking? Grade B, promising: three randomized trials of semaglutide (2025-2026) found less heavy drinking than placebo, but they were small (48 to 108 people), short (8 to 26 weeks) and mostly in people with overweight or obesity.
Biggest trial: weekly semaglutide 2.4 mg plus therapy cut heavy drinking days by 41.1 percentage points versus 26.4 on placebo, and total alcohol by about 1,550 g versus 1,026 g a month (Lancet, May 2026).
The researchers themselves say more trials are needed before off-label use for drinking can be endorsed.

What the randomized trials found

Taken together this is grade B evidence: consistent direction, but small trials. In the Lancet trial, people on semaglutide also had larger drops in a blood marker of drinking (phosphatidylethanol) and in the liver enzyme GGT, which supports the self-reported numbers. Weight loss and drinking reduction moved together, so it is not yet clear how much of the effect is independent of weight.

Randomized, placebo-controlled trials of semaglutide in alcohol use disorder (AUD), read Oct 11, 2026.
Trial	Who	Drug and length	Main result
Klausen et al., Lancet 2026 (SEMALCO)	108 adults seeking treatment for moderate to severe AUD, all with BMI 30+	Semaglutide 2.4 mg weekly vs placebo for 26 weeks, both with up to 10 CBT sessions	Heavy drinking days fell 41.1 vs 26.4 percentage points (difference 13.7, p=0.0015); drinks per drinking day fell 3.5 vs 2.1; weight fell 11.4% vs 2.0%
Schacht et al., Am J Psychiatry 2026	50 adults seeking treatment for moderate to severe AUD, BMI 25+	Oral semaglutide 3 mg then 7 mg daily vs placebo for 8 weeks	Primary outcome (craving after an alcohol cue in the lab) was not significant; heavy drinking days and drinks per drinking day fell more than with placebo; drinks per day did not differ significantly
Hendershot et al., JAMA Psychiatry 2025	48 adults with AUD who were not seeking treatment	Low-dose semaglutide weekly vs placebo for 9 weeks	Less alcohol drunk in a lab self-administration session, fewer drinks per drinking day and less craving

Safety notes if you drink while on a GLP-1

Stomach side effects: in the Lancet trial, nausea affected 57% on semaglutide versus 7% on placebo, and reflux 28% versus 2%. Alcohol can irritate the stomach further.
Dehydration: the Wegovy and Zepbound labels warn that vomiting and diarrhea can cause dehydration and kidney injury. Heavy drinking adds to fluid loss.
Pancreas: alcohol is a leading cause of pancreatitis, and the labels tell you to stop the drug if pancreatitis is suspected (persistent severe stomach pain, sometimes into the back). In the Lancet trial, amylase rose slightly on semaglutide and four people had high readings without symptoms.
Low blood sugar: GLP-1s alone rarely cause it, but the labels warn of hypoglycemia with insulin or sulfonylureas, and alcohol can deepen it.
Do not stop heavy drinking abruptly on your own. Withdrawal can cause seizures; a clinician can help you cut down safely.

If you want help cutting back

Naltrexone, acamprosate and disulfiram are FDA-approved for alcohol use disorder, and therapy such as CBT helps. The NIH-run Alcohol Treatment Navigator lists options. A clinician who prescribes a GLP-1 for weight or diabetes can tell you whether it is reasonable for you, but prescribing one specifically for drinking is off-label.

FAQ

Can you drink alcohol while taking Ozempic or Wegovy?

The Ozempic and Wegovy labels do not prohibit alcohol. Drinking can worsen nausea and dehydration, and with insulin or a sulfonylurea it raises the risk of low blood sugar. Heavy drinking also raises pancreatitis risk, which the labels already warn about, so ask your prescriber what is safe for you.

Does semaglutide reduce alcohol cravings?

In a 2026 Lancet trial of 108 people with alcohol use disorder and obesity, weekly semaglutide 2.4 mg reduced heavy drinking days and craving scores more than placebo over 26 weeks. A smaller 2026 trial of oral semaglutide also reduced heavy drinking days, though its main lab craving measure did not change.

Is Ozempic FDA-approved for alcohol use disorder?

No. No GLP-1 medicine is FDA-approved to treat alcohol use disorder as of October 2026. The approved medicines are naltrexone, acamprosate and disulfiram; using semaglutide for drinking is off-label and the trial authors say more research is needed first.

Why do people on GLP-1s drink less?

GLP-1 receptors sit in brain reward areas as well as the gut, and animal studies show GLP-1 drugs reduce alcohol intake. In human trials, drinking fell alongside weight, so researchers have not yet separated the brain effect from the effect of eating and drinking less overall.

Does tirzepatide (Zepbound or Mounjaro) reduce drinking too?

The randomized trials we reviewed tested semaglutide (and, earlier, exenatide and dulaglutide). The 2026 trial reports list no published placebo-controlled alcohol trial of tirzepatide, so any effect of tirzepatide on drinking is unproven.

GLP-1 side effects: what the FDA labels say →How common nausea is, and the serious warnings.GLP-1s and cancer, thyroid cancer and pancreatitis →What the boxed warning and the studies show.Low-dose naltrexone online →A different naltrexone use, explained.Cheapest way to get a GLP-1 online →How we compare providers →

Sources

Facts on this page come from the sources below, read Oct 11, 2026. We link only to sellers we have an affiliate relationship with and to government and research sources; other sellers' prices are quoted as plain text.